ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

30 links0 made here, not in the record63 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05238831SMMART Adaptive ClinicalTreatment (ACT) TrialOHSU Knight Cancer InstituteEarly Phase 1 · withdrawnRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSSarcomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionBreast NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Ovarian NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Prostatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Pancreatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAlectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAlpelisibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionAnastrozoleIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCarboplatinIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCobimetinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEntrectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEribulinIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFulvestrantIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionPertuzumab/Trastuzumab/Hyal…Entry “Hyaluronidase-zzxf/Pertuzumab/…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIrinotecanIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLetrozoleIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAlbumin-Bound PaclitaxelEntry “Nab-paclitaxel”, read by our n…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNiraparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOlaparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPalbociclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPertuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVemurafenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVinorelbineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedHhAntag691Entry “Vismodegib”, read by our name …›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Alectinib

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Alectinib”the record gives no role
→judged=agrees=agrees
How the 3 judgments split100%of judgments with a known value say Tested
Tested · 3

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2AlectinibClaude Opus 5.5TestedReplaced
Nov 2AlpelisibClaude Opus 5.5TestedReplaced
Nov 2AnastrozoleClaude Opus 5.5TestedReplaced
Nov 2AtezolizumabClaude Opus 5.5TestedReplaced
Nov 2BevacizumabClaude Opus 5.5TestedCurrent
Nov 2CapecitabineClaude Opus 5.5TestedCurrent
Nov 2CarboplatinClaude Opus 5.5TestedCurrent
Nov 2CobimetinibClaude Opus 5.5TestedReplaced
Nov 2EntrectinibClaude Opus 5.5TestedReplaced
Nov 2EribulinClaude Opus 5.5TestedCurrent
Nov 2FulvestrantClaude Opus 5.5TestedReplaced
Nov 2Pertuzumab/Trastuzumab/Hyaluronidase-zzxfClaude Opus 5.5TestedCurrent
Nov 2IrinotecanClaude Opus 5.5TestedCurrent
Nov 2LetrozoleClaude Opus 5.5TestedCurrent
Nov 2Albumin-Bound PaclitaxelClaude Opus 5.5TestedCurrent
Nov 2NiraparibClaude Opus 5.5TestedReplaced
Nov 2OlaparibClaude Opus 5.5TestedReplaced
Nov 2PaclitaxelClaude Opus 5.5TestedCurrent
Nov 2PalbociclibClaude Opus 5.5TestedReplaced
Nov 2PertuzumabClaude Opus 5.5TestedReplaced
Nov 2TrastuzumabClaude Opus 5.5TestedCurrent
Nov 2Ado-Trastuzumab EmtansineClaude Opus 5.5TestedReplaced
Nov 2VemurafenibClaude Opus 5.5TestedCurrent
Nov 2VinorelbineClaude Opus 5.5TestedCurrent
Nov 2HhAntag691Claude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5TestedCurrent
Nov 3FulvestrantClaude Opus 5.5Background · optionCurrent
Nov 3NiraparibClaude Opus 5.5TestedCurrent
Nov 3OlaparibClaude Opus 5.5TestedCurrent
Nov 3PalbociclibClaude Opus 5.5TestedCurrent
Nov 3PertuzumabClaude Opus 5.5TestedCurrent
Nov 3AlectinibClaude Opus 5.5TestedCurrent
Nov 3AlpelisibClaude Opus 5.5Background · optionCurrent
Nov 3AnastrozoleClaude Opus 5.5TestedCurrent
Nov 3CobimetinibClaude Opus 5.5TestedCurrent
Nov 3EntrectinibClaude Opus 5.5TestedCurrent
Nov 3Ado-Trastuzumab EmtansineClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18AlectinibRule based · role ruleTestedAgrees
Nov 18AlpelisibRule based · role ruleTestedOverridden
Nov 18AnastrozoleRule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18CapecitabineRule based · role ruleTestedAgrees
Nov 18CarboplatinRule based · role ruleTestedAgrees
Nov 18CobimetinibRule based · role ruleTestedAgrees
Nov 18EntrectinibRule based · role ruleTestedAgrees
Nov 18EribulinRule based · role ruleTestedAgrees
Nov 18FulvestrantRule based · role ruleTestedOverridden
Nov 18Pertuzumab/Trastuzumab/Hyaluronidase-zzxfRule based · role ruleTestedAgrees
Nov 18IrinotecanRule based · role ruleTestedAgrees
Nov 18LetrozoleRule based · role ruleTestedAgrees
Nov 18Albumin-Bound PaclitaxelRule based · role ruleTestedAgrees
Nov 18NiraparibRule based · role ruleTestedAgrees
Nov 18OlaparibRule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleTestedAgrees
Nov 18PalbociclibRule based · role ruleTestedAgrees
Nov 18PertuzumabRule based · role ruleTestedAgrees
Nov 18TrastuzumabRule based · role ruleTestedAgrees
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleTestedAgrees
Nov 18VemurafenibRule based · role ruleTestedAgrees
Nov 18VinorelbineRule based · role ruleTestedAgrees
Nov 18HhAntag691Rule based · role ruleTestedAgrees
As of nowSarcomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.